Review the Bi-Pro-Test cream source entry. Confirm every ingredient and its assigned strength, along with the package basis, before selecting a preparation.
Already approved? Sign in to see products and pricing for your practice.
One source name gives three amounts per gram without identifying each ingredient. Another field uses a 30 mL package. The gram and milliliter specifications require pharmacy clarification.
The source says 0.25 mg / 100 mg / 0.25 mg per gram. No ingredient mapping is verified, and the 30 mL package cannot be converted to grams from this information.
Explore pharmacy listingsIllustrative packaging. Actual appearance and packaging vary.
1 source entry. Open a pharmacy to review its listings. Repeated or similar names do not establish distinct products or current availability.
| Source preparation / review note | Listed strength / specification | Package |
|---|---|---|
| Bi-Pro-Test Cream 0.25MG/100MG/0.25MG/GMComplete ingredient list and mass / volume clarification required | Unassigned: 0.25 / 100 / 0.25 mg per gram | Source: 30 mL — basis unconfirmed |
Review the exact product with the responsible pharmacy before submitting an order.
Complete practice and account review to get started.
Review the preparation, pharmacy information and account pricing.
Confirm your cart, order details and applicable requirements.
Use saved carts and order history for repeat purchasing.
Participating pharmacies retain prescription review, dispensing and fulfillment responsibilities.
The treating clinician determines suitability and prescribing. Review the exact product’s labeling and pharmacy information.
A blend name is not a complete ingredient specification. The source does not establish which substances correspond to the three amounts.
The clinician and pharmacy should review the complete formulation, intended use and preparation-specific precautions. Neither a familiar ingredient naming pattern nor package-total arithmetic can supply the missing ingredient mapping. FDA: compounded drug information
Confirm the regulatory status of the exact preparation. Compounded drugs are not FDA-approved and do not undergo FDA premarket review for safety, effectiveness or quality. FDA: compounded drug information
Sources checked October 19, 2026. This page provides product information, not diagnosis, treatment selection, dosing or administration instructions.
The supplied entry does not provide a full ingredient list or assign the three amounts to named substances. Obtain the exact formulation from Optimal; this page does not infer ingredients from the blend name.
This page represents 1 source entries. Some names may overlap; confirm the exact product and current availability through your approved account.
No. Product amounts, concentrations and package quantities describe different specifications. The clinician and dispensing pharmacy determine the prescription and instructions.
Interchangeability is not established by a shared ingredient name, matching concentration or release abbreviation. Review each complete formulation and label.
No approval status is established by catalog inclusion. Compounded preparations are not FDA-approved. Confirm the exact product and regulatory status with the pharmacy.
Ordering and account pricing are available to verified, approved clinic accounts. Patients should discuss prescriptions and treatment with their clinician.
Review the current ingredient list, strength units, dosage form, route, release characteristics, package, availability, storage and applicable pharmacy requirements.
Email info@corelinkpharm.com for platform and account questions. Contact the pharmacy for product-specific information.
Start with account access. Keep product review, pricing and ordering together.